Foster Wayne (CIK 1709769) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-03). Recent activity: Sell AVIR (12,132 shares), Buy AVIR (41,333 shares), Sell AVIR (12,062 shares), Buy AVIR (33,333 shares), Buy AVIR (8,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | EVP, Chief Accounting Officer | Sell | 12,132 | $51,440 |
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | EVP, Chief Accounting Officer | Buy | 41,333 | $0 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | EVP, Chief Accounting Officer | Sell | 12,062 | $36,910 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | EVP, Chief Accounting Officer | Buy | 33,333 | $0 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | EVP, Chief Accounting Officer | Buy | 8,000 | $0 |
Source: SEC Form 4 filings · as of 2026-02-03